Post-translational modifications of cancer immune checkpoints: mechanisms and therapeutic strategies
Abstract Immunotherapies, particularly immune checkpoint inhibitors (ICIs), have revolutionized cancer clinical management, but low response rates and treatment resistance remain challenging. Protein post-translational modifications (PTMs) are critical for governing protein expression, localization,...
Saved in:
| Main Authors: | Haiqing Jia, Lei Jiang, Xiaoyu Shen, Huinan Ye, Xinguang Li, Liwei Zhang, Yanyan Hu, Dandan Song, Hui Jia, Zhe Wang |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
BMC
2025-07-01
|
| Series: | Molecular Cancer |
| Subjects: | |
| Online Access: | https://doi.org/10.1186/s12943-025-02397-5 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Necroptosis in cancer: insight from epigenetic, post-transcriptional and post-translational modifications
by: Jinxin Tang, et al.
Published: (2025-07-01) -
Immunoinflammation and post-translational modifications in the aging process
by: Jiaqi Xiao, et al.
Published: (2025-08-01) -
Post‐Translational Modifications in Cilia and Ciliopathies
by: Jie Ran, et al.
Published: (2025-08-01) -
Post-translational modifications of ezrin: a crucial regulator for diseases
by: Yi-Chen Li, et al.
Published: (2025-08-01) -
Evolution and functional cross‐talk of protein post‐translational modifications
by: Pedro Beltrao, et al.
Published: (2013-12-01)